Author:
Beckebaum S.,Cicinnati V.,Frilling A.,Gerken G.
Reference45 articles.
1. Seyam MS, Grunson BK, Neuberger JM. Late mortality in orthotopic liver transplant recipients who survive more than 5 years. Single center experience. Hepatology 2004; 40:Abst. 222.
2. Martin-Davila P, Fortun J, Gutierrez C et al. Analysis of a quantitative PCR assay for CMV infection in liver transplant recipients: an intent to find the optimal cut-off value. J Clin Virol 2005; 33:138–144.
3. Evans PC, Coleman N, Wreghitt TG et al. Cytomegalovirus infection of bile duct epithelial cells, hepatic artery and portal venous endothelium in relation to chronic rejection of liver grats. J Hepatol 1999; 31:913–920.
4. Lake KD. New prophylactic treatment strategy for cytomegalovirus disease. Am J Health Syst Pharm 2003; 60(Suppl 8):S13–S16.
5. Smets F, Sokal EM. Epstein-Barr virus-related lymphoproliferation in children after liver transplant: role of immunity, diagnosis, and management. Pediatr Transplant 2002; 6: 280–287.